scispace - formally typeset
Open AccessJournal ArticleDOI

Tumor extracellular vesicles drive metastasis (it's a long way from home).

Reads0
Chats0
TLDR
The journey of extracellular vesicles from the primary tumor to the future metastatic organ, with a focus on the mechanisms used by EVs to target organs with a specific tropism (i.e., organotropism), and the formation of a pro‐inflammatory and immuno‐tolerant microenvironment is described.
Abstract
Among a plethora of functions, extracellular vesicles released by primary tumors spread in the organism and reach distant organs where they can induce the formation of a premetastatic niche. This constitutes a favorable microenvironment for circulating tumor cells which facilitates their seeding and colonization. In this review, we describe the journey of extracellular vesicles (EVs) from the primary tumor to the future metastatic organ, with a focus on the mechanisms used by EVs to target organs with a specific tropism (i.e., organotropism). We then highlight important tumor EV cargos in the context of premetastatic niche formation and summarize their known effects on extracellular matrix remodeling, angiogenesis, vessel permeabilization, resident cell activation, recruitment of foreign cells, and ultimately the formation of a pro-inflammatory and immuno-tolerant microenvironment. Finally, we discuss current experimental limitations and remaining opened questions in light of metastatic diagnosis and potential therapies targeting PMN formation.

read more

Citations
More filters
Journal ArticleDOI

Circulating tumor cells: Towards mechanical phenotyping of metastasis

TL;DR: In this article , the authors discuss the importance of CTC mechanics and their correlation with metastatic success and how such development could lead to the identification of therapeutically relevant targets.
Journal ArticleDOI

Circulating extracellular vesicles and tumor cells: sticky partners in metastasis.

TL;DR: In this article , the authors discuss the central role of cellular adhesion molecules (CAMs) that are present on extracellular vesicles (EVs) and CTs, as well as their endothelial ligands, in dictating their arrest site and their capacity to exit the vasculature.
Journal ArticleDOI

The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma

TL;DR: In this paper , the authors focused on MALAT1, a marker of serious pathological changes and a factor in the promotion of tumorigenesis, RCAT1 (tumour promoter in RCC), DUXAP9 (a plausible marker of localized ccRCC), TCL6 (exerting tumour-suppressive effects in renal cancer), LINC00342 (acting as an oncogene), AGAP2 Antisense1 (plausible predictor of RCC progression), DLEU2 (factor promoting tumours growth via the regulation of epithelial-mesenchymal transition), NNT-AS1 (sponge of miR-22 contributing to tumour progression), lnc-LSG1 (a factor that may stimulate CCRCC metastasis).
Journal ArticleDOI

Engineering complexity in human tissue models of cancer.

TL;DR: A review of the state of the art in developing and using the human tissue models in cancer research and developmental drug screening can be found in this paper , where the main classes of models providing different levels of biological fidelity and complexity, discuss their advantages and limitations, and propose a framework for designing an appropriate model for a given study.
Journal ArticleDOI

From Promise to Reality: Bioengineering Strategies to Enhance the Therapeutic Potential of Extracellular Vesicles

TL;DR: Extracellular vesicles (EVs) have been the focus of great attention over the last decade, considering their promising application as next-generation therapeutics as mentioned in this paper , considering their ability to shuttle messages between cells.
References
More filters
Journal ArticleDOI

Toward tailored exosomes: The exosomal tetraspanin web contributes to target cell selection

TL;DR: This is the first report on the exosomal tetraspanin web contributing to target cell selection such that predictions can be made on potential targets, which will facilitate tailoring exosomes for drug delivery.
Journal ArticleDOI

Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier

TL;DR: It is shown that cancer-derived extracellular vesicles, mediators of cell–cell communication via delivery of proteins and microRNAs (miRNAs), trigger the breakdown of BBB, and that systemic injection of brain metastatic cancer cell-derived EVs promoted brain metastasis of breast cancer cell lines and are preferentially incorporated into the brain in vivo.
Journal ArticleDOI

Rab27a Supports Exosome-Dependent and -Independent Mechanisms That Modify the Tumor Microenvironment and Can Promote Tumor Progression

TL;DR: These findings offer in vivo validation of the concept that exosome secretion can exert key pathophysiologic roles during tumor formation and progression, but they also highlight the idiosyncratic character of the tumor context.
Related Papers (5)